Abstract
Fabry disease (FD) is a lysosomal storage disorder (LSD) with multisystem manifestations among which skin lesions are common and well-recognized. They may appear early in childhood in both hemizygous males and heterozygous females, their frequency increasing with age. In addition to dermatological lesions, normal-looking skin, as occurs with other tissues, accumulates unmetabolized products in multiple cells of different embryonic origin with variable distribution, biochemical and staining properties and morphological features, according to the type of stored material and the physiopathology of the disease. Globotryaosil-ceramide (Gb3), the most abundant glycosphyngolipid accumulated in FD, can be specifically documented with immunocytochemical methods using a particular monoclonal antibody. On the other hand, ultrastructural characteristics of Gb3 and its distribution in dermal cells are well-defined. Furthermore, the study of unmyelinated and small myelinated fibers in epidermal nerve endings is a reflection of the impaired sensory innervation and the characteristic painful neuropathy present in FD. Therefore, a combination of different technologies in tissues obtained with noninvasive techniques, such as skin biopsy, is advisable and should be considered in order to obtain better insights into FD. This is essential in the case of heterozygous women in whom biochemical diagnosis is often controversial.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Desnick RJ, Ioannou YA, Eng CM (2001) Alpha-galactosidase A deficiency: Fabry disease. In: Scriver C, Beaudet A, Sly W, Valle D, Kinzler DE, Volgestein B (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill Inc, New York, pp 3733–3774
Orteu CH, Jansen T, Lidove O et al (2007) Fabry disease and the skin: data from FOS, the Fabry outcome survey. Br J Dermatol 157:331–337
Ries M, Ramaswami U, Parini R et al (2003) The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr 162:767–772
Larralde M, Boggio P, Amartino H, Chamoles N (2004) Fabry disease: a study of 6 hemizygous men and 5 heterozygous women with emphasis on dermatologic manifestations. Arch Dermatol 140:1440–1446
Mohrenschlager M, Braun-Falco M, Ring J, Abeck D (2003) Fabry disease: recognition and management of cutaneous manifestations. Am J Clin Dermatol 4:189–196
Barba Romero MA, Garcia de Lorenzo y Mateos A, Groupo Espanol de Estudio de FOS (2004) Fabry’s disease in Spain. Study of 24 cases. Med Clin (Barc) 123:57–60
Jansen T, Graue N, Dissemond J, Hillen U, Hentschke M, Grabbe S (2006) Telangiectasias on the neck as a presenting cutaneous sign of Fabry disease. J Dermatol 33:652–654
Fleming C, Rennie A, Fallowfield M, McHenry PM (1997) Cutaneous manifestations of fucosidosis. Br J Dermatol 136:594–597
Kanitakis J, Allombert C, Doebelin B et al (2005) Fucosidosis with angiokeratoma. Immunohistochemical & electronmicroscopic study of a new case and literature review. J Cutan Pathol 32:506–511
Rodriguez-Serna M, Botella-Estrada R, Chabas A et al (1996) Angiokeratoma corporis diffusum associated with beta-mannosidase deficiency. Arch Dermatol 132:1219–1222
Molho-Pessach V, Bargal R, Abramowitz Y et al (2007) Angiokeratoma corporis diffusum in human beta-mannosidosis: report of a new case and a novel mutation. J Am Acad Dermatol 57:407–412
Kawachi Y, Matsu-ura K, Sakuraba H, Otsuka F (1998) Angiokeratoma corporis diffusum associated with galactosialidosis. Dermatology 197:52–54
Kelly B, Kelly E (2006) Angiokeratoma corporis diffusum in a patient with no recognizable enzyme abnormalities. Arch Dermatol 142:615–618
Navarro C (1995) Estudio ultraestructural de la piel. Su contribución al diagnóstico de las enfermedades metabólicas que afectan al Sistema Nervioso Central. University of Barcelona, Barcelona
de Groote CM (1998) Het Electronmicroscopisch Onderzoek van Huidbiopten als Metabole Aandoeningen van het. Zenuwestel. Born-Bunge Stichting, University of Antwerpen, Antwerpen
Brady RO, Gal AE, Bradley RM et al (1967) Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency. N Engl J Med 276:1163–1167
Khine AA, Firtel M, Lingwood CA (1998) CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis. J Cell Physiol 176:281–292
Tetaud C, Falguieres T, Carlier K et al (2003) Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1. J Biol Chem 278:45200–45208
Ceuterick C, Martin JJ (1984) Diagnostic role of skin or conjunctival biopsies in neurological disorders. An update. J Neurol Sci 65:179–191
Hashimoto K, Gross BG, Lever WF (1965) Angiokeratoma Corporis Diffusum (Fabry). Histochemical and Electron Microscopic Studies of the Skin. J Invest Dermatol 44:119–128
Carpenter S (1987) Skin biopsy for diagnosis of hereditary neurologic metabolic disease. Arch Dermatol 123:1618–1621
Goebel HH (1999) Extracerebral biopsies in neurodegenerative diseases of childhood. Brain Dev 21:435–443
Abramovich CM, Prayson RA, McMahon JT, Cohen BH (2001) Ultrastructural examination of the axillary skin biopsy in the diagnosis of metabolic diseases. Hum Pathol 32:649–655
Newton GA, Sanchez RL, Swedo J, Smith EB (1987) Lafora’s disease. The role of skin biopsy. Arch Dermatol 123:1667–1669
Ceuterick-de Groote C, Martin JJ (1998) Extracerebral biopsy in lysosomal and peroxisomal disorders. Ultrastructural findings. Brain Pathol 8:121–132
Alroy J, Ucci AA (2006) Skin biopsy: a useful tool in the diagnosis of lysosomal storage diseases. Ultrastruct Pathol 30:489–503
Askari H, Kaneski CR, Semino-Mora C et al (2007) Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch 451:823–834
Malur PR, Davanageri RS, Bannur HB, Suranagi VV (2008) Lafora’s disease diagnosed on axillary skin biopsy in 3 patients. Indian J Dermatol Venereol Leprol 74:672–673
Kotani M, Hosoya H, Kubo H et al (1994) Evidence for direct binding of intracellularly distributed ganglioside GM2 to isolated vimentin intermediate filaments in normal and Tay-Sachs disease human fibroblasts. Cell Struct Funct 19:81–87
Kanekura T, Fukushige T, Kanda A et al (2005) Immunoelectron-microscopic detection of globotriaosylceramide accumulated in the skin of patients with Fabry disease. Br J Dermatol 153:544–548
Rozenfeld PA, Croxatto O, Ebner R, Fossati CA (2006) Immunofluorescence detection of globotriaosylceramide deposits in conjunctival biopsies of Fabry disease patients. Clin Exp Ophthalmol 34:689–694
Kennedy WR, Wendelschafer-Crabb G (1993) The innervation of human epidermis. J Neurol Sci 115:184–190
McCarthy BG, Hsieh ST, Stocks A et al (1995) Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 45:1848–1855
Lauria G, McArthur JC, Hauer PE, Griffin JW, Cornblath DR (1998) Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy. J. Neurol. Neurosurg. Psychiatry 65:762–766
Urmacher CD (1997) Normal skin. In: Sternberg SS (ed) Histology for pathologists, 2nd edn. Lippincott-Raven, Philadelphia, pp 25–45
Sagebiel RW, Parker F (1968) Cutaneous lesions of Fabry’s disease: glycolipid lipidosis; light and electron microscopic findings. J Invest Dermatol 50:208–213
Navarro C, Teijeira S, Dominguez C et al (2006) Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients. Acta Neuropathol 111:178–185
Cable WJ, Dvorak AM, Osage JE, Kolodny EH (1982) Fabry disease: significance of ultrastructural localization of lipid inclusions in dermal nerves. Neurology 32:347–353
Dvorak AM, Cable WJL, Osage JE, Kolodny EH (1981) Diagnostic electron microscopy: II. Fabry’s disease: use of biopsies from uninvolved skin: acute and chronic changes involving the microvasculature and small unmyelinated nerves. In: Summers SC, Rosen PP (eds) Pathology annual. Appleton-Century-Crofts, New York, pp 139–158
Kahn P (1973) Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain. J Neurol Neurosurg Psychiatry 36:1053–1062
Lao LM, Kumakiri M, Mima H et al (1998) The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis. J Dermatol Sci 18:109–117
Kolodny EH, Cable WJ (1982) Inborn errors of metabolism. Ann Neurol 11:221–232
Tabira T, Goto I, Kuroiwa Y, Kikuchi M (1974) Neuropathological and biochemical studies in Fabry’s disease. Acta Neuropathol 30:345–354
Mohrenschlager M, Ring J, Abeck D (2001) Skin manifestations of Fabry disease. JAMA 286:1315
Fischer EG, Moore MJ, Lager DJ (2006) Fabry disease: a morphologic study of 11 cases. Mod Pathol 19:1295–1301
Eggert AO, Wossner R, Knoll A, Hamm H, Wanner C, Breunig FB (2006) Umbilical angiectases as the sole clinical sign of Fabry disease in a 9-year-old boy. Eur J Pediatr 165:205–206
Amann-Vesti BR, Gitzelmann G, Widmer U, Bosshard NU, Steinmann B, Koppensteiner R (2003) Severe lymphatic microangiopathy in Fabry disease. Lymphat Res Biol 1:185–189
Navarro X, Verdu E, Wendelschafer-Crabb G, Kennedy WR (1997) Immunohistochemical study of skin reinnervation by regenerative axons. J Comp Neurol 380:164–174
Kennedy WR (2004) Opportunities afforded by the study of unmyelinated nerves in skin and other organs. Muscle Nerve 29:756–767
Onishi A, Dyck PJ (1974) Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch Neurol 31:120–127
Scott LJ, Griffin JW, Luciano C et al (1999) Quantitative analysis of epidermal innervation in Fabry disease. Neurology 52:1249–1254
Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC (1998) Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 44:47–59
Kennedy WR, Wendelschafer-Crabb G, Johnson T (1996) Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47:1042–1048
Kennedy WR, Wendelschafer-Crabb G (1996) Utility of skin biopsy in diabetic neuropathy. Semin. Neurol 16:163–171
Hilz MJ, Axelrod FB, Bickel A et al (2004) Assessing function and pathology in familial dysautonomia: assessment of temperature perception, sweating and cutaneous innervation. Brain 127:2090–2098
Polydefkis M, Yiannoutsos CT, Cohen BA et al (2002) Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 58:115–119
Chiang MC, Lin YH, Pan CL, Tseng TJ, Lin WM, Hsieh ST (2002) Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy. Neurology 8(59):1094–1098
Hilz MJ, Stemper B, Kolodny EH (2000) Lower limb cold exposure induces pain and prolonged small fiber dysfunction in Fabry patients. Pain 84:361–365
Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC (1999) Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 53:1634–1640
Llewelyn JG, Gilbey SG, Thomas PK, King RH, Muddle JR, Watkins PJ (1991) Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study. Brain 114:867–892
Periquet MI, Novak V, Collins MP et al (1999) Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 53:1641–1647
Rahman AN, Lindenberg R (1963) The Neuropathology of Hereditary Dystopic Lipidosis. Arch Neurol 9:373–385
Steward VW, Hitchcock C (1968) Fabry’s disease (angiokeratoma corporis diffusum). A report of 5 cases with pain in the extremities as the chief symptom. Pathol Eur 3:377–388
McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW (1998) Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 55:1513–1520
Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR (1999) Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 81:135–145
Acknowledgements
To all patients and their families for their generous and disinterested cooperation. To James Stilwell-Stronge for his help with the English version of this work and to Tania Vázquez for editorial assistance. This work was supported in part by grants from Fondo de Investigacion Sanitaria (PI07/1257 and PI07/90043) and Xunta de Galicia (PGIDIT06PXIB905328PR, INCITE07PXI905221ES and PS08/38).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Netherlands
About this chapter
Cite this chapter
Navarro, C. et al. (2010). Histopathology of Skin in Fabry Disease. In: Elstein, D., Altarescu, G., Beck, M. (eds) Fabry Disease. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9033-1_15
Download citation
DOI: https://doi.org/10.1007/978-90-481-9033-1_15
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9032-4
Online ISBN: 978-90-481-9033-1
eBook Packages: MedicineMedicine (R0)